基本信息来源于合作网站,原文需代理用户跳转至来源网站获取       
摘要:
<strong>Objective: </strong><span style="font-family:""><span style="font-family:Verdana;">To investigate the clinical effects of</span><a name="_Hlk26140736"></a><span style="font-family:Verdana;"> recombinant human interleukin-2 (rhIL-2) combined with </span><a name="_Hlk26140744"></a><span style="font-family:Verdana;">Zhenqi Fuzheng and Baofukang on cervical intraepithelial neoplasia II (CINII) combined with human papilloma virus infection. </span><b><span style="font-family:Verdana;">Methods: </span></b><span style="font-family:Verdana;">There were 593 patients diagnosed with CINII with HPV infection, including 296 in the control group and 297 in the experimental group. The control group was given only Zhenqi Fuzheng oral and Baofukang suppository vaginal medicine. The experimental group was treated with rhIL-2 injection in addition to Zhenqi Fuzheng oral and Baofukang suppository vaginal medicine which is treated for 3 months. After 3 months, Thinprep cytologic test (TCT), human papilloma virus (HPV) quantitative examination and colposcopy biopsy were reviewed. </span><b><span style="font-family:Verdana;">Results:</span></b><span style="font-family:Verdana;"> After 3 months of treatment, the negative conversion rate and total effective rate of HPV in the control group were 58.11% and 70.95% respectively, and the negative conversion rate and total effective rate of the experimental group were 79.46% and 90.57% respectively. There was significant difference between the two groups (p = 0.000). The curative rate of cervical lesions was significantly higher in the test group than in the control group, 89.56%, 68.91%, respectively. The statistical difference between the two groups is significant (p = 0.000). </span><b><span style="font-family:Verdana;">Conclusion:</span></b><span style="font-family:Verdana;"> It has an essential clinical value that HPV infection patients and cervical intraepithelial neoplasia II associated with </span><a name="_Hlk47768779"></a><span style="font-family:Verdana;">HPV infection pati
推荐文章
CD3McAb联合rhIL-2激活的骨髓对白血病细胞杀伤净化作用的研究
CD3McAb
rhIL-2
激活骨髓
杀伤活性
骨髓净化
rhIL-15和rhIL-2诱生的LAK细胞特性比较
LAK细胞
增殖
细胞毒作用
表型
NK细胞
流动相中加SDS测定rhIL-2(Ⅰ)纯度
重组人白介素-2(Ⅰ)
纯度
流动相
十二烷基硫酸钠
rhIL-2 对动物瘢痕成纤维细胞的影响
病理性瘢痕
细胞因子
成纤维细胞
创伤愈合
内容分析
关键词云
关键词热度
相关文献总数  
(/次)
(/年)
文献信息
篇名 Clinical Observation of rhIL-2 Combined with Zhenqi Fuzheng and BaofuKang Suppository in the Treatment of Cervical Intraepithelial Neoplasia II with HPV Infection
来源期刊 妇产科期刊(英文) 学科 医学
关键词 Cervical Intraepithelial Neoplasia II Human Papilloma Virus Recombinant Human Interleukin-2 Zhenqi Fuzheng Baofukang
年,卷(期) 2020,(8) 所属期刊栏目
研究方向 页码范围 1045-1055
页数 11页 分类号 R73
字数 语种
DOI
五维指标
传播情况
(/次)
(/年)
引文网络
引文网络
二级参考文献  (0)
共引文献  (0)
参考文献  (0)
节点文献
引证文献  (0)
同被引文献  (0)
二级引证文献  (0)
2020(0)
  • 参考文献(0)
  • 二级参考文献(0)
  • 引证文献(0)
  • 二级引证文献(0)
研究主题发展历程
节点文献
Cervical
Intraepithelial
Neoplasia
II
Human
Papilloma
Virus
Recombinant
Human
Interleukin-2
Zhenqi
Fuzheng
Baofukang
研究起点
研究来源
研究分支
研究去脉
引文网络交叉学科
相关学者/机构
期刊影响力
妇产科期刊(英文)
月刊
2160-8792
武汉市江夏区汤逊湖北路38号光谷总部空间
出版文献量(篇)
642
总下载数(次)
0
论文1v1指导